Alerts will be sent to your verified email
Verify EmailKIMIABL
Kimia Biosciences
|
Fredun Pharma
|
Murae Organisor
|
|
---|---|---|---|
Operational Metrics
|
|||
Unclassified
|
|||
R&D as a % of Total Sales
|
4.44 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
-18.99 % | 8.25 % | 13.01 % |
5yr average Equity Multiplier
|
10.34 | 3.06 | 2.32 |
5yr Average Asset Turnover Ratio
|
1.23 | 0.96 | 1.28 |
5yr Avg Net Profit Margin
|
-0.2 % | 2.91 % | 6.28 % |
Price to Book
|
594.81 | 3.82 | 0.68 |
P/E
|
0.0 | 29.44 | 0.0 |
5yr Avg Cash Conversion Cycle
|
42.45 Days | 119.14 Days | 626.89 Days |
Inventory Days
|
76.54 Days | 128.65 Days | 169.42 Days |
Days Receivable
|
86.33 Days | 82.94 Days | 303.46 Days |
Days Payable
|
118.68 Days | 146.5 Days | 39.01 Days |
5yr Average Interest Coverage Ratio
|
0.94 | 2.35 | 11.38 |
5yr Avg ROCE
|
4.07 % | 14.5 % | 20.4 % |
5yr Avg Operating Profit Margin
|
3.78 % | 8.98 % | 10.81 % |
5 yr average Debt to Equity
|
4.48 | 0.79 | 0.8 |
5yr CAGR Net Profit
|
n/a | 19.37 % | 3.59 % |
5yr Average Return on Assets
|
0.18 % | 2.89 % | 5.43 % |
Shareholdings
|
|||
Promoter Holding
|
74.94 % | 49.13 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.91 % | -70.04 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Kimia Biosciences
|
Fredun Pharma
|
Murae Organisor
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|